搜尋結果
Ozempic Maker Novo Nordisk Beats Profit Forecasts Amid Weight Loss Drug Frenzy
Forbes· 2 日前Danish pharma giant Novo Nordisk raised its 2024 outlook and beat profit expectations in its first-quarter earnings Thursday ...
Novo Nordisk trims price for blockbuster obesity drug as competition heats up
Reuters· 1 日前, opens new tab raised its 2024 outlook on Thursday as the Danish drugmaker races to boost ...
FTC Seeks More Information on $16.5 Billion Novo-Catalent Deal
The Wall Street Journal· 12 小時前The request signals that the agency is reviewing whether the deal could be anticompetitive ...
Amgen investors await weight-loss drug data
Reuters· 3 日前, opens new tab investors eyeing dramatic share price gains for rivals with successful obesity ...
Morgan Stanley says India is having its longest and best bull market ever. Here's an ETF to ...
CNBC· 1 日前India's historic stock market rally shows no signs of slowing down and there is still time ...
Author Post: How SMART Goals Sabotage Success (and the Brain Science of What Works)
Forbes· 21 小時前It’s easy to fall into the trap of what is called the Performance Mindset. When our definition ...
The Best Walking Shoes For Flat Feet, According To A Podiatrist
Forbes· 2 日前The best walking shoes for flat feet evenly redistribute your body weight to alleviate stress on your ...
Novo Nordisk: Wegovy, Ozempic prices in US fell in Q1
Reuters· 2 日前, opens new tab has seen the price of its hugely popular weight-loss drug Wegovy and diabetes ...
18 Slim Wallets Professional Stylists Recommend for Less Bulgy Pockets
The Wall Street Journal· 14 小時前A minimalist wallet with room for a few cards and a bit of cash will hold everything you need ...
Here's a point-by-point rundown on why we're buying more of 3 portfolio stocks
CNBC· 1 日前... Jim Cramer's Charitable Trust will own: 840 shares of SWK, increasing its weighting ...